These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35690410)

  • 1. Genotoxicity evaluation of medical devices: A regulatory perspective.
    Kumaravel TS; Sathya TN; Balaje R; Pradeepa P; Yogaraj D; Murali MR; Navaneethakrishnan KR; Murugan S; Jha AN
    Mutat Res Rev Mutat Res; 2022; 789():108407. PubMed ID: 35690410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Site of contact genotoxicity' assessment for implants - Potential use of single cell gel electrophoresis in biocompatibility testing of medical devices.
    Kumaravel TS; Brabu B; Parthiban N; Murugan SS; Jha AN
    Toxicol Lett; 2021 May; 341():59-67. PubMed ID: 33548342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A compilation of safety impact information for extractables associated with materials used in pharmaceutical packaging, delivery, administration, and manufacturing systems.
    Jenke D; Carlson T
    PDA J Pharm Sci Technol; 2014; 68(5):407-55. PubMed ID: 25336416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of the Threshold of Toxicological Concern (TTC) to Biological Evaluation of Medical Devices].
    Liu C; Shi Y; Du X; Sun X; Liu J
    Zhongguo Yi Liao Qi Xie Za Zhi; 2019 Jul; 43(4):282-285. PubMed ID: 31460722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creating a Holistic Extractables and Leachables (E&L) Program for Biotechnology Products.
    Li K; Rogers G; Nashed-Samuel Y; Lee H; Mire-Sluis A; Cherney B; Forster R; Yeh P; Markovic I
    PDA J Pharm Sci Technol; 2015; 69(5):590-619. PubMed ID: 26429108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilizing relative potency factors (RPF) and threshold of toxicological concern (TTC) concepts to assess hazard and human risk assessment profiles of environmental metabolites: a case study.
    Terry C; Rasoulpour RJ; Knowles S; Billington R
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):301-17. PubMed ID: 25584438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genotoxicity assessment approach for botanical materials demonstrated with Poria cocos.
    Sun B; Huang B; Sica VP; Baker TR; Pfuhler S
    Food Chem Toxicol; 2021 Oct; 156():112521. PubMed ID: 34461192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health related guide values for drinking-water since 1993 as guidance to assess presence of new analytes in drinking-water.
    Dieter HH
    Int J Hyg Environ Health; 2014 Mar; 217(2-3):117-32. PubMed ID: 23820379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.
    Kirkland D; Pfuhler S; Tweats D; Aardema M; Corvi R; Darroudi F; Elhajouji A; Glatt H; Hastwell P; Hayashi M; Kasper P; Kirchner S; Lynch A; Marzin D; Maurici D; Meunier JR; Müller L; Nohynek G; Parry J; Parry E; Thybaud V; Tice R; van Benthem J; Vanparys P; White P
    Mutat Res; 2007 Mar; 628(1):31-55. PubMed ID: 17293159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical Characterization and Non-targeted Analysis of Medical Device Extracts: A Review of Current Approaches, Gaps, and Emerging Practices.
    Sussman EM; Oktem B; Isayeva IS; Liu J; Wickramasekara S; Chandrasekar V; Nahan K; Shin HY; Zheng J
    ACS Biomater Sci Eng; 2022 Mar; 8(3):939-963. PubMed ID: 35171560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotoxicity testing approaches for the safety assessment of substances used in food contact materials prior to their authorization in the European Union.
    Bolognesi C; Castoldi AF; Crebelli R; Barthélémy E; Maurici D; Wölfle D; Volk K; Castle L
    Environ Mol Mutagen; 2017 Jun; 58(5):361-374. PubMed ID: 28556235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Threshold of toxicological concern (TTC) for botanicals - Concentration data analysis of potentially genotoxic constituents to substantiate and extend the TTC approach to botanicals.
    Mahony C; Bowtell P; Huber M; Kosemund K; Pfuhler S; Zhu T; Barlow S; McMillan DA
    Food Chem Toxicol; 2020 Apr; 138():111182. PubMed ID: 32058013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotoxicity assessment: opportunities, challenges and perspectives for quantitative evaluations of dose-response data.
    Menz J; Götz ME; Gündel U; Gürtler R; Herrmann K; Hessel-Pras S; Kneuer C; Kolrep F; Nitzsche D; Pabel U; Sachse B; Schmeisser S; Schumacher DM; Schwerdtle T; Tralau T; Zellmer S; Schäfer B
    Arch Toxicol; 2023 Sep; 97(9):2303-2328. PubMed ID: 37402810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamically monitoring cellular γ-H2AX reveals the potential of carcinogenicity evaluation for genotoxic compounds.
    Qu M; Xu H; Li W; Chen J; Zhang Y; Xu B; Li Z; Liu T; Guo L; Xie J
    Arch Toxicol; 2021 Nov; 95(11):3559-3573. PubMed ID: 34510228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the utility of the Threshold of Toxicological Concern (TTC) and its exclusions in the biocompatibility assessment of extractable chemical substances from medical devices.
    Patlewicz G; Nelms M; Rua D
    Comput Toxicol; 2022 Nov; 24():1-11. PubMed ID: 36405647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of in vitro test systems using bacterial and mammalian cells for genotoxicity assessment within the "health-related indication value (HRIV) concept.
    Prantl EM; Kramer M; Schmidt CK; Knauer M; Gartiser S; Shuliakevich A; Milas J; Glatt H; Meinl W; Hollert H
    Environ Sci Pollut Res Int; 2018 Feb; 25(5):3996-4010. PubMed ID: 27928753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The BlueScreen HC assay to predict the genotoxic potential of fragrance materials.
    Thakkar Y; Joshi K; Hickey C; Wahler J; Wall B; Etter S; Smith B; Griem P; Tate M; Jones F; Oudraogo G; Pfuhler S; Choi C; Williams G; Greim H; Eisenbrand G; Dekant W; Api AM
    Mutagenesis; 2022 Apr; 37(1):13-23. PubMed ID: 35302169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of reducing the top concentration used in the in vitro chromosomal aberration test in CHL cells on the evaluation of industrial chemical genotoxicity.
    Morita T; Honma M; Morikawa K
    Mutat Res; 2012 Jan; 741(1-2):32-56. PubMed ID: 22020093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vivo comet assay: use and status in genotoxicity testing.
    Brendler-Schwaab S; Hartmann A; Pfuhler S; Speit G
    Mutagenesis; 2005 Jul; 20(4):245-54. PubMed ID: 15899933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.